U.S. Whole Exome Sequencing Market Size & Outlook
U.S. whole exome sequencing market, 2018-2030 (US$M)
Related Markets
U.S. whole exome sequencing market highlights
- The U.S. whole exome sequencing market generated a revenue of USD 168.5 million in 2022 and is expected to reach USD 591.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 17% from 2023 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2022.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Whole exome sequencing market data book summary
| Market revenue in 2022 | USD 168.5 million |
| Market revenue in 2030 | USD 591.4 million |
| Growth rate | 17% (CAGR from 2022 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, BGI Group, Pacific Biosciences of California Inc, Oxford Nanopore Technologies PLC, Azenta Inc, Novogene, Eurofins Scientific SE |
Other key industry trends
- In terms of revenue, U.S. accounted for 46.7% of the global whole exome sequencing market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. whole exome sequencing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 54.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Whole Exome Sequencing Market Scope
Whole Exome Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. whole exome sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to whole exome sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 62.55% in 2024. Horizon Databook has segmented the U.S. whole exome sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Whole Exome Sequencing Product Outlook (Revenue, USD Million, 2018-2030)
- Consumables
- Instruments
- Services
- U.S. Whole Exome Sequencing Technology Outlook (Revenue, USD Million, 2018-2030)
- Sequencing by Synthesis
- Others
- ION Semiconductor Sequencing
- U.S. Whole Exome Sequencing Workflow Outlook (Revenue, USD Million, 2018-2030)
- Sequencing
- Presequencing
- Data Analysis
- U.S. Whole Exome Sequencing Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery & Development
- Personalized Medicine
- Clinical Diagnostics
- Others
- U.S. Whole Exome Sequencing End Use Outlook (Revenue, USD Million, 2018-2030)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Others
Reasons to subscribe to U.S. whole exome sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. whole exome sequencing market databook
-
Our clientele includes a mix of whole exome sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. whole exome sequencing market, including forecasts for subscribers. This country databook contains high-level insights into U.S. whole exome sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. whole exome sequencing market report size, by product, 2018-2030 (US$M)
U.S. Whole Exome Sequencing Market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
